Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2015

Open Access 01-08-2015 | Epidemiology

Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients

Authors: Annemieke Witteveen, Ingrid M. H. Vliegen, Gabe S. Sonke, Joost M. Klaase, Maarten J. IJzerman, Sabine Siesling

Published in: Breast Cancer Research and Treatment | Issue 3/2015

Login to get access

Abstract

The objective of this study was to develop and validate a time-dependent logistic regression model for prediction of locoregional recurrence (LRR) of breast cancer and a web-based nomogram for clinical decision support. Women first diagnosed with early breast cancer between 2003 and 2006 in all Dutch hospitals were selected from the Netherlands Cancer Registry (n = 37,230). In the first 5 years following primary breast cancer treatment, 950 (2.6 %) patients developed a LRR as first event. Risk factors were determined using logistic regression and the risks were calculated per year, conditional on not being diagnosed with recurrence in the previous year. Discrimination and calibration were assessed. Bootstrapping was used for internal validation. Data on primary tumours diagnosed between 2007 and 2008 in 43 Dutch hospitals were used for external validation of the performance of the nomogram (n = 12,308). The final model included the variables grade, size, multifocality, and nodal involvement of the primary tumour, and whether patients were treated with radio-, chemo- or hormone therapy. The index cohort showed an area under the ROC curve of 0.84, 0.77, 0.70, 0.73 and 0.62, respectively, per subsequent year after primary treatment. Model predictions were well calibrated. Estimates in the validation cohort did not differ significantly from the index cohort. The results were incorporated in a web-based nomogram (http://​www.​utwente.​nl/​mira/​influence). This validated nomogram can be used as an instrument to identify patients with a low or high risk of LRR who might benefit from a less or more intensive follow-up after breast cancer and to aid clinical decision making for personalised follow-up.
Literature
1.
go back to reference Lu WL, Jansen L, Post WJ et al (2009) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114:403–412. doi:10.1007/s10549-008-0023-4 CrossRefPubMed Lu WL, Jansen L, Post WJ et al (2009) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114:403–412. doi:10.​1007/​s10549-008-0023-4 CrossRefPubMed
2.
go back to reference Moossdorff M, van Roozendaal LM, Strobbe LJ et al (2014) Maastricht delphi consensus on event definitions for classification of recurrence in breast cancer research. J Natl Cancer Inst. doi:10.1093/jnci/dju288 PubMed Moossdorff M, van Roozendaal LM, Strobbe LJ et al (2014) Maastricht delphi consensus on event definitions for classification of recurrence in breast cancer research. J Natl Cancer Inst. doi:10.​1093/​jnci/​dju288 PubMed
3.
go back to reference Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717. doi:10.1016/S0140-6736(05)66544-0 CrossRef Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717. doi:10.​1016/​S0140-6736(05)66544-0 CrossRef
6.
8.
go back to reference Lin P-H, Yeh M-H, Liu L-C et al (2013) Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy. J Surg Oncol 108:352–357. doi:10.1002/jso.23403 CrossRefPubMed Lin P-H, Yeh M-H, Liu L-C et al (2013) Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy. J Surg Oncol 108:352–357. doi:10.​1002/​jso.​23403 CrossRefPubMed
9.
go back to reference Komoike Y, Akiyama F, Iino Y et al (2006) Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 106:35–41. doi:10.1002/cncr.21551 CrossRefPubMed Komoike Y, Akiyama F, Iino Y et al (2006) Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 106:35–41. doi:10.​1002/​cncr.​21551 CrossRefPubMed
10.
go back to reference Cortesi L, Marcheselli L, Guarneri V et al (2013) Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years. Int J Cancer 132:E58–E65. doi:10.1002/ijc.27795 CrossRefPubMed Cortesi L, Marcheselli L, Guarneri V et al (2013) Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years. Int J Cancer 132:E58–E65. doi:10.​1002/​ijc.​27795 CrossRefPubMed
11.
go back to reference Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106. doi:10.1016/S0140-6736(05)67887-7 CrossRefPubMed Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106. doi:10.​1016/​S0140-6736(05)67887-7 CrossRefPubMed
13.
go back to reference Nagao T, Kinoshita T, Tamura N et al (2013) Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy. Int J Clin Oncol 18:54–61. doi:10.1007/s10147-011-0343-y CrossRefPubMed Nagao T, Kinoshita T, Tamura N et al (2013) Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy. Int J Clin Oncol 18:54–61. doi:10.​1007/​s10147-011-0343-y CrossRefPubMed
15.
22.
go back to reference Nederlandse Kankerregistratie (2013) Codeerhandleiding Nederlandse Kankerregistratie Nederlandse Kankerregistratie (2013) Codeerhandleiding Nederlandse Kankerregistratie
28.
go back to reference Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301–1308PubMedCentralCrossRef Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301–1308PubMedCentralCrossRef
29.
go back to reference Peduzzi P, Concato J, Kemper E et al (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379CrossRefPubMed Peduzzi P, Concato J, Kemper E et al (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379CrossRefPubMed
32.
go back to reference Buuren S, Groothuis-Oudshoorn K (2011) MICE: multivariate imputation by chained equations in R. J Stat Softw 45 Buuren S, Groothuis-Oudshoorn K (2011) MICE: multivariate imputation by chained equations in R. J Stat Softw 45
34.
go back to reference Steyerberg EW, Harrell FE, Borsboom GJ et al (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54:774–781CrossRefPubMed Steyerberg EW, Harrell FE, Borsboom GJ et al (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54:774–781CrossRefPubMed
36.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed
Metadata
Title
Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients
Authors
Annemieke Witteveen
Ingrid M. H. Vliegen
Gabe S. Sonke
Joost M. Klaase
Maarten J. IJzerman
Sabine Siesling
Publication date
01-08-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3490-4

Other articles of this Issue 3/2015

Breast Cancer Research and Treatment 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine